Decision Diagnostics Net Worth
Decision Diagnostics Net Worth Breakdown | DECN |
Decision Diagnostics Net Worth Analysis
Decision Diagnostics' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Decision Diagnostics' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Decision Diagnostics' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Decision Diagnostics' net worth analysis. One common approach is to calculate Decision Diagnostics' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Decision Diagnostics' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Decision Diagnostics' net worth. This approach calculates the present value of Decision Diagnostics' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Decision Diagnostics' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Decision Diagnostics' net worth. This involves comparing Decision Diagnostics' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Decision Diagnostics' net worth relative to its peers.
Enterprise Value |
|
To determine if Decision Diagnostics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Decision Diagnostics' net worth research are outlined below:
| Decision Diagnostics generated a negative expected return over the last 90 days | |
| Decision Diagnostics has some characteristics of a very speculative penny stock | |
| Decision Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Decision Diagnostics currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Decision Diagnostics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 462.23 K. | |
| Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations. | |
| Decision Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Major Breakthrough Lucid Diagnostics Secures Game-Changing Insurance Coverage for Cancer Test - StockTitan |
Follow Decision Diagnostics' market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 35.79 K.Market Cap |
|
Project Decision Diagnostics' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (8.44) | (8.02) | |
| Return On Capital Employed | (2.61) | (2.48) | |
| Return On Assets | (4.72) | (4.49) | |
| Return On Equity | (70.55) | (67.03) |
When accessing Decision Diagnostics' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Decision Diagnostics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Decision Diagnostics' profitability and make more informed investment decisions.
Evaluate Decision Diagnostics' management efficiency
Decision Diagnostics has return on total asset (ROA) of (0.2122) % which means that it has lost $0.2122 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (81.6052) %, meaning that it created substantial loss on money invested by shareholders. Decision Diagnostics' management efficiency ratios could be used to measure how well Decision Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of March 2025, Return On Tangible Assets is likely to grow to -8.02. In addition to that, Return On Capital Employed is likely to grow to -2.48. At this time, Decision Diagnostics' Other Current Assets are very stable compared to the past year. As of the 21st of March 2025, Total Current Assets is likely to grow to about 2.5 M, while Total Assets are likely to drop about 5.2 M.| Last Reported | Projected for Next Year | ||
| Tangible Book Value Per Share | (0.01) | (0.01) | |
| Enterprise Value Over EBITDA | (37.47) | (39.35) | |
| Price Book Value Ratio | 8.93 | 9.38 | |
| Enterprise Value Multiple | (37.47) | (39.35) | |
| Price Fair Value | 8.93 | 9.38 | |
| Enterprise Value | 6.4 M | 4 M |
Decision Diagnostics showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Enterprise Value Revenue 1.4379 | Revenue | Quarterly Revenue Growth (0) | Revenue Per Share | Return On Equity |
Decision Diagnostics Earnings per Share Projection vs Actual
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.